Abstract

During the last decade the use of ventricular assist devices (VADs) for patients with severe heart failure has increased tremendously. However, flow disturbances, mainly high shear induced by the device is associated with bleeding complications. Shear stress-induced changes in VWF conformation are associated with a loss of high molecular weight multimers (HMW) of VWF and an increased risk of bleeding. This phenomenon and its cause will be elaborated and reviewed in the following.

Highlights

  • In 1958, Edward Heyde observed a link between the presence of aortic stenosis (AS) and gastrointestinal (GI)-bleeding of idiopathic origin in 10 patients [1, 2]

  • Recent studies in mice models reported that plasmin can function as a back-up for ADAMTS-13 to proteolyze von Willebrand factor (VWF) and mitigate thrombocytopenic purpura (TTP) symptoms, but only in conditions of supraphysiological increased plasmin activity to overcome the inhibition by α2antiplasmin and plasminogen activator inhibitor 1 (PAI-1) [17]

  • Sakatsume et al reported that patients with continuous flow left ventricular assist device (LVAD) support and with GI-bleeding exhibited a more severe loss of VWF high molecular weight multimers (HMW)-multimers compared to patients without GI-bleeding [61]

Read more

Summary

Acquired von Willebrand Syndrome in Patients With Ventricular Assist Device

During the last decade the use of ventricular assist devices (VADs) for patients with severe heart failure has increased tremendously. Flow disturbances, mainly high shear induced by the device is associated with bleeding complications. Shear stress-induced changes in VWF conformation are associated with a loss of high molecular weight multimers (HMW) of VWF and an increased risk of bleeding. This phenomenon and its cause will be elaborated and reviewed in the following. Reviewed by: Shiu-Ki Rocky Hui, Baylor College of Medicine, United States Coen Maas, University Medical Center Utrecht, Netherlands. Specialty section: This article was submitted to Hematology, a section of the journal

INTRODUCTION
VON WILLEBRAND FACTOR
SHEAR AND VON WILLEBRAND FACTOR
ACQUIRED VON WILLEBRAND SYNDROME IN PATIENTS WITH VAD SUPPORT
Lower recurrence of GI bleed compared to a None reported
Findings
CONCLUSIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.